Dr. Erin M. Bertino M.D.
Hematologist-Oncologist | Hematology & Oncology
410 W 10th Ave Columbus OH, 43210About
Dr. Erin Bertino is a hematologist oncologist practicing in Columbus, OH. Dr. Bertino specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Northeast Ohio Medical University Medical
Ohio University Heritage College of Osteopathic Medicine 2004
Provider Details
Expert Publications
Data provided by the National Library of MedicineClinical Trials
- Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
- Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
- Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
- Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
- Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer
Treatments
- Lung Cancer, Mesothelioma, Thymus Cancers And More
- Chronic Pain
- Anemia
- Breast Cancer
- Lung Cancer
Fellowships
- Hematology/Oncology: Ohio State University Wexner Medical Center 2008
Dr. Erin M. Bertino M.D.'s Practice location
Columbus, OH 43210Get Direction
Dr. Erin M. Bertino M.D.'s reviews
Write ReviewRecommended Articles
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery
It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- This New Zealand Native Beat Cancer Eight Times
Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
Nearby Providers
- Mrs. Sudhathi Chennuru M.D.300 Polaris Pkwy Westerville Ohio 43082
- Dr. Basem William MD500 Thomas Ln Columbus OH 43214
- Dr. Folefac Edmund M.D.460 W 10th Ave Columbus OH 43210
- Dr. Seema Bhat MD460 W 10TH AVE COLUMBUS OH 43210
- Dr. Craig C Hofmeister MD300 W 10th Ave Columbus OH 43210
- Dr. Christopher S George M.D.810 Jasonway Ave Columbus OH 43214